英文摘要 |
Human metapneumovirus (hMPV), discovered in 2001, imposes a significant disease burden worldwide, particularly affecting children, the elderly, and immunocompromised individuals with higher infection rates and severity. This comprehensive review provides an overview of the epidemiology, clinical manifestations, diagnostics, treatment, prevention, and control of hMPV infection. hMPV infections can present with a range of respiratory symptoms, from mild upper respiratory tract to severe lower respiratory tract infections, leading to hospitalization and death. Currently, there is no specific treatment for hMPV infection, and symptomatic management is recommended for mild cases, whereas severe cases require aggressive intensive care support, including oxygen therapy, respiratory support, and mechanical ventilation. The diagnosis of an hMPV infection is challenging because it shares clinical features with other respiratory viral infections. Commonly used diagnostic methods include polymerase chain reaction, immunofluorescence assay, and enzyme-linked immunosorbent assay. There are ongoing efforts to develop vaccines to prevent hMPV infections; however, further research is required to evaluate their safety and efficacy. Developing effective vaccines and treatment methods remains the current focus of research. Prevention measures include promoting personal hygiene, frequent hand washing, reducing contact with infected individuals, and avoiding crowded and poorly ventilated areas to minimize the risk of contracting an hMPV infection. Enhancing public awareness and education regarding hMPV is also important for prevention. |